Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05779787

COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)

Whereas PCI before TAVR was previously recommended despite its uncertain prognostic role, recent data underline the possibility of a postponed coronary intervention using a commissural alignment technique. This approach allows easy coronary re-engagement through the valve stent frame with a trade off paid of procedure complexity.

Considering the prevalence of coronary artery disease (CAD) and the increasing percentage of younger patients treated with TAVI, investigate whether a simpler procedure with random implantation of Navitor valve is not inferior in terms of coronary re-access, is required The key point of the project will be the evaluation of the feasibility of coronary re-engagement after a Navitor valve randomly implanted.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

ASST GOM Niguarda

Milan, Lombardy, 20162, Italy

Location status: Recruiting

Location contact

Giuseppe Esposito, MD

CONTACT

[email protected]

+393278393131

About this study

Transcatheter Aortic Valve Implantation (TAVI) is recommended by European and American guidelines to treat patients with aortic stenosis regardless of procedural risk (1, 2). In the last decades the increasing percentage of younger patients treated with TAVI, reflect the extensive indications in lower risk setting, highlighting the importance of easy coronary re-engagement after valve implantation. Considering the prevalence and the progression of a pre-existing coronary artery disease (CAD), the timing of coronary intervention should be accurate selected (3) addressing the percentage of unplanned percutaneous coronary intervention (PCI) after TAVI (4). In fact, while PCI before TAVR was previously recommend despite the uncertain prognostic role (5), recent data remarks the possibility of a postponed coronary intervention using a commissural alignment technique (6) that allows a predictable stent frame position in the sinus of Valsalva (7). Moreover, following the emerging concept of easy re-access, only a few types of prostheses have been shown to have an high degree of stent position predictability after implantation, leading to a limited option in terms of prosthesis choice. Furthermore, to achieve the best results with commissural alignment technique, accurate procedure planning and operator's expertise are required in order to properly manage the valve specific orientation in the aorta with consequent increase in time, radiation and procedure complexity.

However, geometry of the stent frame (height and size) and the anatomical characteristics of patients have to be enlisted as contributory factors to difficult coronary re-engagement and need to be evaluate in order to establish the feasibility of the re-access after TAVR.

The investigators' findings could provide data regarding the non-inferiority rate of coronary cannulation after a simpler procedure with Navitor implantation without alignment technique. Due to these results, the valves portfolio available in patients with coronary artery disease that needed PCI after TAVR, could be larger and various allowing the best protheses choice according to the patient's anatomy and operator's expertise. Finally, knowing the predictors of difficult re-engagement for both types of valves, regardless of implantation technique, could be interesting for an even more valve tailored approach.

The purpose of this study is to investigate the feasibility of coronary re-engagement after randomly (not aligned) Navitor implantation, as already perform in current clinical practice, due to a lower predictable orientation of this type of valve.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patients to be included in this registry should have all the following criteria:

  • Severe, symptomatic aortic stenosis with an indication to TAVI

Exclusion criteria

and definition

Patients excluded in this registry should have all the following criteria:

  • Valve in Valve procedure
  • Hemodynamical instability
  • TAVR performed from other access (not femoral)
  • No-CT Planned TAVR
  • TAVR performed with Chimney Technique

Treatment and study plan

TAVR Aligned

Procedure

Investigate the feasibility of coronary re-engagement after commissural alignment technique in terms of success rate (%) and procedure complexity taking into account radiations, time and contrast used.

TAVR Random

Procedure

TAVR Random Feasibility comparison of coronary re-engagement between the randomly implanted Navitor valve (unaligned) and the others implanted with the commissural alignment technique in terms of success rate (%) and complexity of the procedure, taking into account radiation, time and contrast used

Primary outcomes

  1. Coronary re-access after TAVR procedure

    Time frame: During procedure

    Re-engagement of LMCA and RCA after valve implantation is defined as selective cannulation and subsequent selective angiography. All others type of re-engagement will be classify as "non selective". We will stratify also the modality of re-cannulation in relation to the position of the valves' stent struts as "above", "across" and "behind".

Secondary outcomes

  1. Total Implant Time

    Time frame: During procedure

    Total time required for valve implantation. We count the time from the alignment in the aorta to the end of valve opening (Alignment Fluoroscopy time + Implantation Fluoroscopy time).

  2. Total Implant Fluoroscopy Time

    Time frame: During procedure

    Total Fluoroscopy time required for valve implantation. We count the time from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).

  3. Total Implant Radiations

    Time frame: During procedure

    Total Radiations required for valve implantation. We count the radiations used from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).

  4. Total Implant Contrast

    Time frame: During procedure

    Total Contrast required for valve implantation

  5. Alignment Radiation

    Time frame: During procedure

    Radiation required for commissural alignment

  6. Alignment Fluoroscopy Time

    Time frame: During procedure

    Fluoroscopy time required for commissural alignment

  7. Implant Radiation

    Time frame: During procedure

    Radiation required for valve implantation

  8. Implant Fluoroscopy Time

    Time frame: During procedure

    Fluoroscopy time required for valve implantation

  9. Implant Contrast

    Time frame: During procedure

    Contrast required for valve implantation

  10. Re-Engagement Radiation

    Time frame: During procedure

    Radiation required for re-engagement

  11. Re-Engagement Fluoroscopy Time

    Time frame: During procedure

    Fluoroscopy time required for coronary re-engagement

  12. Re-Engagement Contrast used

    Time frame: During procedure

    Contrast required for coronary re-engagement

  13. Re-Engagement Time

    Time frame: During procedure

    Time required for coronary re-engagement

Study contacts

Contact information is provided by the study sponsor or research team.

Giuseooe Esposito, MD

CONTACT

[email protected]

+393278393131

Sponsors and collaborators

Lead sponsor

Niguarda Hospital

Other

Registry information

Acronym: COMFORT

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Mar 22, 2023
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.